FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2105477241> ?p ?o ?g. }

• W2105477241 endingPage "234" @default.
• W2105477241 startingPage "229" @default.
• W2105477241 abstract "Background: The combination of epirubicin, cisplatin, and infusional 5-fluorouracil (ECF) currently represents a standard and effective regimen for the treatment of advanced gastroesophageal cancer. The use of doxorubicin as an alternative to epirubicin in the ECF regimen has not been evaluated. Methods: Thirty-two patients with metastatic adenocarcinoma of the stomach, gastroesophageal junction, or esophagus were treated with cisplatin 60 mg/m2 and doxorubicin 30 mg/m2 repeated every 21 days, in combination with infusional 5-fluorouracil 200 mg/m2/day (ACF). Results: Major objective responses were observed in 28 percent of patients (46 percent previously untreated; 13 percent previously treated), with one complete response. The median progression-free survival was 4.0 months, and the median overall survival was 5.8 months (9.3 months previously untreated; 4.5 months previously treated). The major (Grade 3–4) toxicities were neutropenia (34 percent), anorexia (31 percent), nausea (28 percent), diarrhea (19 percent), and stomatitis (16 percent). Conclusion: In comparison with historical data taken from published trials of ECF, the ACF regimen appears similar in efficacy when differences in prior treatment status are taken into account. However, ACF appears to be associated with a higher incidence of major toxicities. Our findings therefore support the continued use of epirubicin rather than doxorubicin in combination chemotherapy regimens for advanced gastroesophageal cancer." @default.
• W2105477241 created "2016-06-24" @default.
• W2105477241 creator A5003723404 @default.
• W2105477241 creator A5017947396 @default.
• W2105477241 creator A5020468392 @default.
• W2105477241 creator A5022263231 @default.
• W2105477241 creator A5049314303 @default.
• W2105477241 creator A5072333217 @default.
• W2105477241 creator A5088474933 @default.
• W2105477241 creator A5090604653 @default.
• W2105477241 date "2006-01-01" @default.
• W2105477241 modified "2023-10-04" @default.
• W2105477241 title "A Phase II Study of Doxorubicin, Cisplatin, and 5-Fluorouracil in Patients with Advanced Adenocarcinoma of the Stomach or Esophagus" @default.
• W2105477241 cites W12356482 @default.
• W2105477241 cites W1525737532 @default.
• W2105477241 cites W1848862702 @default.
• W2105477241 cites W1920900131 @default.
• W2105477241 cites W1940613095 @default.
• W2105477241 cites W1944693814 @default.
• W2105477241 cites W1976651872 @default.
• W2105477241 cites W1992408996 @default.
• W2105477241 cites W2024949026 @default.
• W2105477241 cites W2040143851 @default.
• W2105477241 cites W2058680827 @default.
• W2105477241 cites W2108779475 @default.
• W2105477241 cites W2111513457 @default.
• W2105477241 cites W2130522735 @default.
• W2105477241 cites W2143863553 @default.
• W2105477241 cites W2336505540 @default.
• W2105477241 cites W4244497714 @default.
• W2105477241 cites W4293241248 @default.
• W2105477241 doi "https://doi.org/10.1080/07357900600633924" @default.
• W2105477241 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16809148" @default.
• W2105477241 hasPublicationYear "2006" @default.
• W2105477241 type Work @default.
• W2105477241 sameAs 2105477241 @default.
• W2105477241 citedByCount "11" @default.
• W2105477241 countsByYear W21054772412012 @default.
• W2105477241 countsByYear W21054772412013 @default.
• W2105477241 countsByYear W21054772412015 @default.
• W2105477241 countsByYear W21054772412017 @default.
• W2105477241 countsByYear W21054772412018 @default.
• W2105477241 crossrefType "journal-article" @default.
• W2105477241 hasAuthorship W2105477241A5003723404 @default.
• W2105477241 hasAuthorship W2105477241A5017947396 @default.
• W2105477241 hasAuthorship W2105477241A5020468392 @default.
• W2105477241 hasAuthorship W2105477241A5022263231 @default.
• W2105477241 hasAuthorship W2105477241A5049314303 @default.
• W2105477241 hasAuthorship W2105477241A5072333217 @default.
• W2105477241 hasAuthorship W2105477241A5088474933 @default.
• W2105477241 hasAuthorship W2105477241A5090604653 @default.
• W2105477241 hasConcept C126322002 @default.
• W2105477241 hasConcept C141071460 @default.
• W2105477241 hasConcept C2776694085 @default.
• W2105477241 hasConcept C2776755627 @default.
• W2105477241 hasConcept C2777819096 @default.
• W2105477241 hasConcept C2778239845 @default.
• W2105477241 hasConcept C2778496288 @default.
• W2105477241 hasConcept C2779422922 @default.
• W2105477241 hasConcept C2780456651 @default.
• W2105477241 hasConcept C2780580376 @default.
• W2105477241 hasConcept C2780835546 @default.
• W2105477241 hasConcept C2781303535 @default.
• W2105477241 hasConcept C2781413609 @default.
• W2105477241 hasConcept C71924100 @default.
• W2105477241 hasConcept C90924648 @default.
• W2105477241 hasConceptScore W2105477241C126322002 @default.
• W2105477241 hasConceptScore W2105477241C141071460 @default.
• W2105477241 hasConceptScore W2105477241C2776694085 @default.
• W2105477241 hasConceptScore W2105477241C2776755627 @default.
• W2105477241 hasConceptScore W2105477241C2777819096 @default.
• W2105477241 hasConceptScore W2105477241C2778239845 @default.
• W2105477241 hasConceptScore W2105477241C2778496288 @default.
• W2105477241 hasConceptScore W2105477241C2779422922 @default.
• W2105477241 hasConceptScore W2105477241C2780456651 @default.
• W2105477241 hasConceptScore W2105477241C2780580376 @default.
• W2105477241 hasConceptScore W2105477241C2780835546 @default.
• W2105477241 hasConceptScore W2105477241C2781303535 @default.
• W2105477241 hasConceptScore W2105477241C2781413609 @default.
• W2105477241 hasConceptScore W2105477241C71924100 @default.
• W2105477241 hasConceptScore W2105477241C90924648 @default.
• W2105477241 hasIssue "3" @default.
• W2105477241 hasLocation W21054772411 @default.
• W2105477241 hasLocation W21054772412 @default.
• W2105477241 hasOpenAccess W2105477241 @default.
• W2105477241 hasPrimaryLocation W21054772411 @default.
• W2105477241 hasRelatedWork W1526433935 @default.
• W2105477241 hasRelatedWork W1976440095 @default.
• W2105477241 hasRelatedWork W2083924870 @default.
• W2105477241 hasRelatedWork W2277607698 @default.
• W2105477241 hasRelatedWork W2370897712 @default.
• W2105477241 hasRelatedWork W2382109049 @default.
• W2105477241 hasRelatedWork W2385131479 @default.
• W2105477241 hasRelatedWork W2465069930 @default.
• W2105477241 hasRelatedWork W2947501674 @default.
• W2105477241 hasRelatedWork W4247856874 @default.
• W2105477241 hasVolume "24" @default.
• W2105477241 isParatext "false" @default.

• next